Interleukin-6 involvement in mesothelioma pathobiology: inhibition by interferon ? immunotherapy

Author:

Bielefeldt-Ohmann H.,Marzo A. L.,Himbeck R. P.,Jarnicki A. G.,Robinson B. W. S.,Fitzpatrick D. R.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Reference38 articles.

1. Bielefeldt-Ohmann H, Sabara M, Lawman MJP, Griebel P, Babiuk LA (1988) A monoclonal antibody detects a macrophage maturation antigen which appears independently of class II antigen expression: reactivity of monoclonal EBM11 with bovine macrophages. J Immunol 140:2201

2. Bielefeldt-Ohmann H, Fitzpatrick DR, Marzo AL, Jarnicki AG, Himbeck RP, Davis MR, Manning LS, Robinson BWS (1994) Patho- and immunobiology of malignant mesothelioma: characterisation of tumour infiltrating leukocytes and cytokine production in a murine model. Cancer Immunol Immunother 39:347

3. Bielefeldt-Ohmann H, Fitzpatrick DR, Marzo AL, Jarnicki AG, Musk AW, Robinson BWS (1995) The potential for interferon-? based therapy in mesothelioma: assessment in a murine model. J Interferon Cytokine Res 15:213

4. Burger R, Gramatzki M (1993) Responsiveness of the interleukin (IL)-6-dependent cell line B9 to IL-11. J Immunol Methods 158:147

5. Chahinian AP, Pajak TF, Holland JF, Norton L, Ambinder RM, Mandel EM (1982) Diffuse malignant mesothelioma, prospective evaluation of 69 patients. Ann Intern Med 69:356

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3